UCF Researcher Studies Probiotics as Potential Treatment for Chronic Acid Reflux and Esophageal Cancer Risk

A University of Central Florida researcher is currently investigating the use of probiotics as a potential treatment for chronic acid reflux and its associated risk of esophageal cancer. The study examines whether introducing beneficial bacteria into the digestive system can mitigate the damage caused by stomach acid flowing back into the esophagus, a condition that affects millions of people globally and serves as a primary risk factor for esophageal malignancies.

Chronic acid reflux frequently causes symptoms such as heartburn, belching, chest discomfort, and difficulty swallowing. Because persistent exposure to stomach acid can lead to cellular changes in the esophagus, medical professionals often categorize the condition as a precursor to esophageal cancer, which currently maintains a low five-year survival rate. By focusing on the role of probiotics, the research aims to determine if these supplements offer a viable method for managing the condition and reducing the long-term health risks linked to the disease.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 3, 2026

Author

GOAI